Immune Design Corp. (IMDZ) Stock Price, Quote, News and Overview
NASDAQ:IMDZ - Nasdaq -
IMDZ Quote, Performance and Key Statistics
5.85
0 (0%)
The current stock price of IMDZ is 5.85 null. In the past month the price increased by 0.34%. In the past year, price increased by 85.71%.
About IMDZ
Company Profile
Immune Design Corp. is a clinical-stage immunotherapy company. The Company is focused on the development of immune-based therapies based on its DCVex (TM) and GLAAS (TM) discovery platforms for cancer and other chronic conditions. Its product candidates in Phase I clinical trials comprise LV305, CMB305, and G305 for the treatment of solid tumor types, such as breast cancer, melanoma, non-small cell lung cancer, ovarian cancer, or sarcoma; and G100 for the treatment of patients with merkel cell carcinoma. Immune Design Corp. is headquartered in Seattle, Washington.
Company Info
Immune Design Corp.
1616 EASTLAKE AVENUE EAST SUITE 310
SEATTLE WA 98102
CEO: Carlos Paya
Phone: 206-682-0645
Immune Design Corp. / IMDZ FAQ
What is the stock price of Immune Design Corp. today?
The current stock price of IMDZ is 5.85 null.
What is the ticker symbol for Immune Design Corp. stock?
The exchange symbol of Immune Design Corp. is IMDZ and it is listed on the Nasdaq exchange.
On which exchange is IMDZ stock listed?
IMDZ stock is listed on the Nasdaq exchange.
What is Immune Design Corp. worth?
Immune Design Corp. (IMDZ) has a market capitalization of 282.94M null. This makes IMDZ a Micro Cap stock.
What are the support and resistance levels for Immune Design Corp. (IMDZ) stock?
Immune Design Corp. (IMDZ) has a support level at 5.85 and a resistance level at 5.86. Check the full technical report for a detailed analysis of IMDZ support and resistance levels.
Should I buy Immune Design Corp. (IMDZ) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IMDZ, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IMDZ, evaluating the profitability, health, valuation and growth aspects
- Immune Design Corp. (IMDZ) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Immune Design Corp. (IMDZ) Sales and EPS estimates to see what analysts future expectations are.
- Immune Design Corp. (IMDZ) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Immune Design Corp. (IMDZ) Insider and Institutional Ownership to learn about the owners and their transactions.
- Immune Design Corp. (IMDZ) Stock Chart to make your own analysis
- Immune Design Corp. (IMDZ) Latest news and press-releases to stay up to date.
Does Immune Design Corp. (IMDZ) stock pay dividends?
IMDZ does not pay a dividend.
What is the Price/Earnings (PE) ratio of Immune Design Corp. (IMDZ)?
Immune Design Corp. (IMDZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.15).
IMDZ Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to IMDZ. When comparing the yearly performance of all stocks, IMDZ is one of the better performing stocks in the market, outperforming 99.57% of all stocks.
IMDZ Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to IMDZ. IMDZ has a great financial health rating, but its profitability evaluates not so good.
IMDZ Financial Highlights
Over the last trailing twelve months IMDZ reported a non-GAAP Earnings per Share(EPS) of -1.15. The EPS increased by 46.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -2493.53% | ||
| ROA | -54.24% | ||
| ROE | -59.52% | ||
| Debt/Equity | 0 |